Renal tubular acidosis
- Synonyms
- RTA, distal RTA, proximal RTA, hyperchloremic acidosis, type 4 RTA
- Specialty
- Internal medicine · Nephrology
- Images
- Ultrasound 1
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (1)
UltrasoundDefinition
Renal tubular acidosis (RTA) comprises disorders in which the kidney excretes hydrogen ions inadequately or reabsorbs filtered bicarbonate inadequately. The result is a chronic metabolic acidosis with a normal anion gap, usually with hyperchloremia and frequently with disturbances of potassium balance.
Classification
Type 1 (distal)
- Defect RTA-1: impaired H⁺ secretion in collecting duct (α-intercalated cell).
- Urine pH in RTA-1: > 5.5 despite severe acidosis.
- Potassium in RTA-1: hypokalemia.
- Classic complication RTA-1: nephrocalcinosis, calcium-phosphate stones, osteomalacia.
Type 2 (proximal)
- Defect RTA-2: impaired HCO₃ reabsorption in proximal tubule.
- Urine pH in RTA-2: variable, < 5.5 with severe acidosis (distal intact).
- Potassium RTA-2: hypokalemia (often).
- Complication/associated disease: Fanconi syndrome (glucosuria, phosphaturia, aminoaciduria, uricosuria).
Type 4 (hyperkalemic)
- Potassium RTA-4: hyperkalemia.
- Classic cause RTA-4: hyporeninemic hypoaldosteronism in diabetes mellitus, lupus, HIV.
Laboratory values by type
Plasma bicarbonate: in type 1 frequently < 15 mmol/L, occasionally < 10 mmol/L; in type 2 usually 12–20 mmol/L; in type 4 usually > 17 mmol/L. Type 3 is very rare (carbonic anhydrase II deficiency) and is considered a mixed form of types 1 and 2.
Occurrence & epidemiology
Type 4 is the most common form; type 1 is rare and type 2 very rare. Sporadic cases of type 1 mainly affect adults (primary forms almost always women), while familial forms usually present in childhood.
Aetiopathogenesis
Causes
- Type 1: autoimmune diseases with hypergammaglobulinemia (especially Sjögren syndrome, rheumatoid arthritis), nephrocalcinosis, medullary sponge kidney, chronic obstructive uropathy, liver cirrhosis, sickle cell anemia, certain drugs; familial forms usually autosomal dominant
- Type 2: mostly as part of Fanconi syndrome or light chain nephropathy in multiple myeloma; also vitamin D deficiency, heavy metals, Wilson disease, cystinosis and certain drugs
- Type 4: aldosterone deficiency or lack of aldosterone action on the distal tubule, usually as hyporeninemic hypoaldosteronism in diabetic nephropathy or chronic interstitial nephritis; also primary adrenal insufficiency, obstruction, pseudohypoaldosteronism and drugs affecting the renin-angiotensin-aldosterone system
Clinical features
RTA is often asymptomatic and is detected through laboratory findings. In types 1 and 2, hypokalemia may cause muscle weakness, hyporeflexia and even paralysis. Type 1 leads to nephrocalcinosis and kidney stones through hypercalciuria, hypocitraturia and alkaline urine; chronic kidney disease is common. Bone pain and osteomalacia in adults or rickets in children occur in type 2 and sometimes type 1. Type 2 may cause volume depletion through renal salt and water losses. Type 4 is usually mild; severe hyperkalemia may cause cardiac arrhythmias or paralysis.
Diagnosis
- Suspected in any unexplained metabolic acidosis with a normal anion gap and in unexplained hypokalemia or hyperkalemia
- Arterial blood gas to confirm metabolic acidosis and to exclude respiratory alkalosis with compensatory acidosis
- Serum electrolytes, creatinine, urea and urine pH in all patients
- Urine anion gap (urine sodium + potassium − chloride): markedly negative with extrarenal losses (mostly gastrointestinal; about −30 to −50 mmol/L), positive with renal bicarbonate loss or RTA
- Type 1: urine pH remains > 5.5 during systemic acidosis; normal kidneys lower urine pH to < 5.2 within 6 hours of acidosis (acid loading test if needed)
- Type 2: during bicarbonate loading, urine pH rises above 7.5 and the fractional excretion of bicarbonate exceeds 15%
- Type 4: an appropriate underlying condition, chronically elevated potassium, normal or mildly decreased bicarbonate; usually low plasma renin activity and low aldosterone with normal cortisol
Treatment principles
- The central principle is correction of metabolic acidosis with alkali therapy and of associated potassium disturbances.
- In the hyperkalaemic form, hyperkalaemia and mineralocorticoid deficiency are treated and causative medications are reviewed.
- Underlying diseases are treated as well; therapy helps prevent nephrocalcinosis, kidney stones and bone damage.
Specific treatment regimens with drugs and doses are covered in the InnereFuchs app.
Keep learning in the app
Further reading (open access)
Cross-references
More topics: Nephrology
- Acute kidney injury
- Nephrotic syndrome
- Chronic kidney disease
- Nephritic syndrome and glomerulonephritis
- Acute interstitial nephritis
- Acute pyelonephritis
- Autosomal dominant polycystic kidney disease (ADPKD)
- Bartter and Gitelman syndromes
- Diabetic kidney disease
- Focal segmental glomerulosclerosis (FSGS)
- Goodpasture syndrome (anti-GBM disease)
- Hantavirus infection (nephropathia epidemica)
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the InnereFuchs app – free, in your browser or as an app.
Related pages: Acute kidney injury · Nephrotic syndrome · Chronic kidney disease
Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.